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Klotho proteins (α- and β-Klotho) are transmembrane proteins whose extracellular domain is 
secreted into blood and urine by ectodomain shedding. As such they behave as circulating proteins 
that regulate cell metabolism, endothelial function and calcium homeostasis, as well as modulating 
the lifespan connected activity of Fibroblast Growth Factors (FGFs, mainly 21 and 23) and other mole-
cules (1). Recent data have shown that highest levels of plasma circulating Klotho are associated with 
a lower cardiovascular risk, thereby suggesting a possible role for Klotho in cardiovascular diseases 
(2). However, although Klotho has been identified in various organs, including kidney, brain, adi-
pose tissue and intestine, it is unknown whether cardiomyocytes express Klotho and FGFs and, if so, 
whether high cardiovascular risk can be associated with cardiac expression of Klotho, FGFs and other 
related molecules.
We examined myocardial biopsies from 20 patients with an estimated 10-year atherosclerotic car-
diovascular disease (ASCVD) risk in the range of 5% to 7.5% and 10 age-matched control subjects 
with an estimated 10-year ASCVD risk of <5% (3) undergoing cardiac surgery other than coronary 
artery by-pass. Both groups of patients were statin naive, had normal hemoglobin A1c, normal coro-
nary arteries on left heart catheterization, and had LDL cholesterol levels between 70 and 189 mg/
DL. Using immunohistochemistry methods, we evaluated Klotho and FGFs expression in human car-
diomyocytes, and whether higher ASCVD risk influenced the expression of other molecules involved 
in endoplasmic reticulum stress (GRP78), oxidative stress (SOD1, NFkB) and inflammation (iNOS, 
eNOS).
Cardiomyocytes of patients with a higher ASCVD risk exhibited lower expression of Klotho, but 
also higher expression of FGFs, as compared to cardiomyocytes of patients with a reduced ASCVD 
risk. Furthermore, higher ASCVD risk was associated with significantly increased expression of 
GRP78, SOD1, NFkB and iNOS (all p<0.05). This study shows for the first time that Klotho proteins 
are inherently expressed in human cardiomyocytes and also that cardiac expression of Klotho is 
down regulated in higher ASCVD risk patients, while the expression of FGFs and other stress-relat-
ed molecules involved in myocyte damage, such as GRP78, SOD1, NFkB and iNOS, is significantly 
increased. Further studies are warranted to investigate the association of klotho, FGFs and related 
molecules expression with cardiovascular risk.
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